$IBRX case study CCXI: 1) CCXI reports positive phase 3 data in 2019 ( stock rockets 🚀) 2) falls back to earth in Spring 2021 3) CCXI files for approval in July 2021 4) CCXI receives approval in October 2021 Stock chart follows news (May be an indication of how IBRX will respond with similar announcements). See attachment of CCXI chart over time.
6
3